Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

This study is testing an experimental cancer drug called CID-078 in people with advanced solid tumors that have stopped responding to standard treatments, to evaluate its safety, how the body processes it, and early signs of effectiveness. **You may be eligible if...** - You are 18 years or older - You have an advanced or metastatic solid tumor that has progressed on or is no longer responding to available treatments - You have adequate organ function (liver, kidneys, blood counts) - You are in reasonably good physical health **You may NOT be eligible if...** - You have received certain prior treatments within a required washout period - You have active brain metastases - You have serious infections or autoimmune conditions - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.